JAGX
Jaguar Animal Health IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$3.65M
P/E Ratio
—
EPS
$-22.97
Beta
0.29
52W High
$13.25
52W Low
$0.28
50-Day MA
$0.50
200-Day MA
$1.35
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
200.00
PEG Ratio
-0.02
About Jaguar Animal Health Inc
Jaguar Health, Inc., a commercial-stage pharmaceutical company, focuses on developing prescription drugs for people and animals with gastrointestinal upset, specifically chronic debilitating diarrhea. The company is headquartered in San Francisco, California.
Fundamentals
| Revenue (TTM) | $11.51M |
| Gross Profit (TTM) | $7.74M |
| EBITDA | $-43.20M |
| Operating Margin | -632.00% |
| Return on Equity | -411.60% |
| Return on Assets | -61.50% |
| Revenue/Share (TTM) | $4.93 |
| Book Value | $-2.83 |
| Price-to-Book | 1.62 |
| Price-to-Sales (TTM) | 0.32 |
| EV/Revenue | 4.237 |
| EV/EBITDA | -0.63 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -7.80% |
| Shares Outstanding | $13.02M |
| Float | $12.16M |
| % Insiders | 10.34% |
| % Institutions | 0.50% |
Historical Volatility
HV 10-Day
172.07%
HV 20-Day
137.81%
HV 30-Day
122.51%
HV 60-Day
137.70%
HV Rank
—
Volatility is currently expanding
Data last updated: 4/28/2026